Get Permission Kumar and Kumar: Clinical and microbiological profile of Hansen’s diseases in a tertiary care centre of southwest Bihar


Introduction

Leprosy or Hansen’s disease is a slowly progressive infection caused by mycobacterium Lepra. It is a chronic granulomatous disease that primarily effect skin. Mycobacterium leprae causes two strikingly different patterns of disease tuberculoid and lepromatous which is determined by T-helper lymphocyte response to it.1, 2

Leprosy is oldest recognised disease of civilisation and considered as contagious, mutilating and incurable. It has a terrifying image in the history as patient develops deformity and excluded from the society.3 But with the effort of World health organisation and government of individual country and introduction of MDT it became curable and deformity was prevented. Now WHO has launched "Global Leprosy Strategy 2016–2020: Accelerating towards a leprosy-free world".3 Bihar is state in India share high number of leprosy cases having prevalence rate of 1.18 (21,353 new cases) in 2017-18.4, 5

After going through various literatures we have found that there are different views among researcher about clinicoepidemiology and microbiological profile of Hansen disease in India. Semwal S, Joshi D, Goel G, Asati D, Kapoor N from central India has reported that early clinical detection, and morphological diagnosis is a challenge in new patients. He has further added that histological finding should be correlated with clinical finding.6 Thakkar S, Patel SV from Gujarat has reported that histopathological finding is must in doubtful cases.7 Ramesh Marne Bhat, Prakash Chaitra study from south India points towards high circulation of lepra bacilli in the community in the elimination era of Hansen disease.8 Wagh AN, Mugudalabetta S, Gutierrez NO, et al has pointed towards a serious concern about community-based leprosy case detection campaigns in Bihar. ”They have reported from Bihar that false positive diagnosis is a major issue and decline in false positive diagnosis is not statistically significant."9

Present study has been designed primarily to study the clinical presentation and microbiological profile of patients presenting with symptoms of Hansen disease and secondarily to know the smear positivity of patients with clinical manifestation of leprosy.

Materials and Methods

This is a prospective cross sectional observational study conducted in the department of dermatology and microbiology Narayan Medical College and Hospital Jamuhar, Rohtas.(Bihar) from September 2018 to August 2020.

Ethics

Before start of this study an approval from institutional ethics committee was taken. A written informed consent was obtained from all patients before enrolling them for study.

Selection of patients

During the study period patients attending dermatology outpatient department with the clinical manifestation of Hansen disease were enrolled for this study. Patients who were diagnosed previously and taking treatment were excluded from this study. Based on these criteria 144 patients were enrolled for this study.

Method

After enrolment of patients a detail clinical examination was done and demographic information of patient was recorded on predesigned Performa. After taking consent from enrolled patients slit skin smear was obtained as pre standard protocol. Smears were stained with modified Ziehl-Neelsen stain 0.5% Sulphuric acid was used as decolouriser. Slide was examined under oil emersion microscope. Ridley's logarithmic scale was used for Bacteriological Index (BI).10, 11

Statistical analysis

Data were recorded in excel sheet and statistical Analysis was done with software SPSS-14 version. Quantitative data were calculated as percentage and proportions.

Result

In present two year prospective observational study 32884 patients were attended dermatology OPD and out of them 144 patients have clinical manifestation of Hansen’s disease that was 0.43% of total dermatological OPD.

Table 1

Demography of the patients

Variables

Number

Percentage

Total OPD patients in DVL in study period

32884

100%

Patients with clinical manifestation of leprosy

144

0.43%

Number of Slit skin smear done for AFB

144

100 %

Finding of staining

Negative

114

79.16%

Positive

30

20.83%

Sex

Male

100

69.44%

Female

44

30.55%

All patients with clinical manifestation were underwent slit smear examination for acid fast bacillus. Among these 144 patients, 114 (79.16%) patients were slit skin smear for AFB negative and rest 30 (20.83%) were positive for AFB. There was male predominance (69.44% vs 30.55%).

Table 2

Distribution of bacteriological index of smear among AFB positive patients

Bacteriological index

Number

Percentage

1+

8

26.27%

2+

2

6.67%

3+

2

6.67%

4+

1

3.34%

5+

1

3.34%

6+

16

53.34%

Figure 1

Distribution of bacteriological index

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/b9ad9cd3-b0d7-437c-b031-5c3afcfb3205image1.png

Among 30 patients with 16 (53.34%) patients have bacteriological index 6+ and 8 patients have bacteriological index 1+. Bacteriological index 2+ and 3+ was present in 6.675 % patients each.

Figure 2

Microbiological study of lesions

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/b9ad9cd3-b0d7-437c-b031-5c3afcfb3205image2.png
Table 3

Relation between age and smear positivity

Age of patients

Smear staining done (n=144)

AFB positive (n=30)

0-10

3(2.028%)

0

11-20

24(16.66%)

0

21-30

33(22.91%)

6(20%)

31-50

55(38.19%)

18(60%)

51 and above

29(20.13%)

6(20%)

Figure 3

Relation between of smear staining done, AFB positivity and age.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/b9ad9cd3-b0d7-437c-b031-5c3afcfb3205image3.png

All patients below 20 years of age were slit smear staining smear negative for AFB. In our study 55(38.19%) patients with clinical manifestation were from 31 to 50 years of age among them 18(30 % of total AFB positive) was AFB positive. Number of patients from 20 to 31 years was 22.91% and among them 6(20% of total AFB positive) were slit smear positive for AFB. Similarly 29 22.91% patients above 51 years of age was and among them 6(20% of total AFB positive) were slit smear positive for AFB.

Table 4

Clinical presentation of patients and smear positivity

Type of lesion

Total patients

Smear positive

Nodule/plaque

12(8.34%)

7(23.34%)

Hypopigmented macule

122(84.72%)

22(73.34%)

Loss of sensation

10(6.94%)

1(3.34%)

Figure 4

Distribution of clinical, presentation

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/b9ad9cd3-b0d7-437c-b031-5c3afcfb3205image4.png
Figure 5

Clinical presentation of leprosy,

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/b9ad9cd3-b0d7-437c-b031-5c3afcfb3205image5.png

Regarding type of lesion as per Table 4, nodule and papule was present in 12(8.34%) patients out of them 7 (23.34% of total AFB positive) were smear staining positive for AFB. Hypopigmented macule was present in 122(84.72%) patients out of them 22 (73.34% of total AFB positive) were smear staining positive for AFB. Loss of sensation was present in 10(6.94%) patients out of them only 1 (3.34% of total AFB positive) was smear staining positive for AFB.

Discussion

Hensens disease is a slowly progressive chronic granulomatous disease caused by Mycobacterium Leprae. Appropriate diagnosis with histopathological correlation has become essential in present situation when the cases of Hansen’s diasease are on decline. In present study we have observed that out of all patients attending dermatology in two year duration 0.43% patients were presented with clinical manifestation of Hansen’s disease and we have taken sample for slit smear staining from all patients. Among 144 patients 20.83% were AFB positive and there was male predominance. Mahajan R, Ninama K, et al has reported 112 cases in one year duration, Tralsawala K, Umrigar D.et al reported 329 cases in his 5 year of study and Das NK, De A, Naskar B et al has reported 114 cases in his 2 year of study. So there is variation in the number of cases in various studies from different region of India. But in all study there is male predominance which supports our study.12, 13, 14 In our study 20.83% patients has slide positive for AFB, it is higher in the study (38%) of Subhash Bishnoi et al but supported by the work of Giridhar, M & Arora et al (21%).15, 16

We have observed that most of the patients (53.34%) have lesions with bacteriological index 6+, and 26.27% patients have bacteriological index 1+. Bacteriological index 2+ and 3+ was present in 6.675 % patients each and bacteriological index 4+ and 5 + was present in 3.34% patients. So in our study patients with high bacterial load is more in our community. This finding is supported by the work of Ghosh, R.R. & Sikdar, S. & Ghosh, A.P. & Chatterjee, M.. (2018) et al and Kilikdar, M., Gedam, D., Pisey, A., Ambhore, N., & Karykarte, R et al. 17, 18 Vinay KN, Hedge SG et al from south India reported that in his study patient with bacteriological index 1+ were most common.19

Most common age group presented with clinical symptom and AFB positive were in 3rd and 4th decade of life. Ages below 20 years was less commonly effected and were AFB negative. Which corroborates with the study of Jindal, Nidhi & Shanker et al and Kalita JM, Nag VL, Yedale K et al. 20, 21

Regarding clinical presentation Hypopigmented macule were common presentation and AFB positive was most frequent in them which is supported by the work of Moorthy BN, Kumar P et al.22 Roy P, Dhar R, Patro P et.al has reported that multiple well-defined hypopigmented plaques with loss of sensations was more common lesion in his study which partially support our study.23

Conclusion

From present study we can conclude that there was male predominance and in most of the patients who were smear staining positive have bacteriological index more than 6+. Most common age group presented with clinical symptom and AFB positive were in 3rd and 4th decade of life. Hypopigmented macules were common presentation and AFB positive was most frequent in them. So even in post eradication era patients with high bacterial load were common and microbiological and histopathological examination is important to reduce false positive diagnosis.

Source of Funding

No financial support was received for the work within this manuscript.

Conflict of Interest

The authors declare they have no conflict of interest.

References

1 

R H Gelber Leprosy Harrisons principal of internal medicine20th Edn.McGraw Hill publication1260

2 

W J Britton D N Lockwood LeprosyLancet2004363120910.1016/s0140-6736(04)15952-7

3 

Leprosy elimination, World health organisation2020https://www.who.int/lep/leprosy/en/

4 

S Singh Leprosy on rise, Bihar may see all-time high of 50,000 new cases this year, The Indian express UpdatedLeprosy on rise20197https://indianexpress.com/article/india/leprosy-cases-bihar-naubatpur-town-lcdc-nlep-5558650/

5 

Central Leprosy Division. National Leprosy Eradication Programme Annual Report 2015–16 201620152031New Delhi, Indiahttp://nlep.nic.in/pdf/revised

6 

S Semwal D Joshi G Goel D Asati N Kapoor Clinico-Histological Correlation in Hansen's Disease: Three-year Experience at a Newly Established Tertiary Care Center in Central IndiaIndian J Dermatol20186364658

7 

S Thakkar S V Patel Clinical profile of leprosy patients: A prospective studyIndian J Dermatol20145921586210.4103/0019-5154.127676

8 

R M Bhat P Chaitra Profile of New Leprosy Cases Attending a South Indian Referral HospitalInt Scholarly Res Notices2011201310.1155/2013/579024

9 

A N Wagh S Mugudalabetta N O Gutierrez K Padebettu A K Pandey B K Pandey Does appreciative inquiry decrease false positive diagnosis during leprosy case detection campaigns in Bihar, India? An operational research studyPLOS Neglected Trop Dis20181212e000700410.1371/journal.pntd.0007004

10 

W H Jopling A C Mcdougall Diagnostic tests: skin smearsHandbook of Leprosy5th Edn.CBS Publishers & Distributors New Delhi, India20005861

11 

V K Mahajan Slit-skin smear in leprosy: lest we forget it !Indian J Lepr20138517783

12 

R Mahajan K Ninama V Jain F E Bilimoria S Lakhani A 5 year study of leprosy patients in a tertiary care centreInd J Clin Exp Dermatol2018432326

13 

K Tralsawala D Umrigar Leprosy reactions: a prospective study at tertiary care hospital of South GujaratInt J Res Dermatol2020656586410.18203/issn.2455-4529

14 

A De N K Das B Naskar A Sil S Das A Sarda A quality of life study of patients with leprosy attending the dermatology OPD of a tertiary care center of Eastern IndiaIndian J Dermatol2020651426

15 

Subhash Bishnoi M D Arvind Verma M D Manisha Nijhawan A Clinico-epidemiological profile of Hansen’s disease in a tertiary care institute of Western India: A six year studyGulf J Dermatol Venereol20192612430

16 

M Giridhar G Arora K Lajpal K Chahal Clinicohistopathological concordance in leprosy - A clinical,histopathological and bacteriological study of 100 casesIndian J Leprosy20128421725

17 

R R Ghosh S Sikdar A P Ghosh M Chatterjee Profile of disease in leprosy patients diagnosed in a tertiary care centre in kolkata duringIndian J Leprosy20149011927

18 

M Kilikdar D Gedam A Pisey N Ambhore R Karykarte Leprosy Profiles In Post Elimination Stage: Experience At A Tertiary Care HospitalNational J Integr Res Med201892647

19 

K N Vinay S G Hedge A clinical profile of leprosy patients in a tertiary hospital, Karnataka: a retrospective studyInt J Res Dermatol201956157

20 

N Jindal V Shanker G Tegta M Gupta G Verma Clinico-epidemiological trends of leprosy in Himachal Pradesh: A five year studyIndian J Leprosy2009811739

21 

V L Nag J M Kalita K Yedale Spectrum of leprosy among suspected cases attending a teaching hospital in Western Rajasthan, IndiaJ Family Med Primary Care2020962781410.4103/jfmpc.jfmpc_77_20

22 

B N Moorthy P Kumar K R Chatura H R Chandrasekhar P K Basavaraja Histopathological correlation of skin biopsies in leprosyIndian J Dermatol Venereol Leprol200167299301

23 

P Roy R Dhar P Patro Histopathological study of leprosy patients in a tertiary care hospital in Navi MumbaiInt J Health Sci Res201992612



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijced.2020.072


Article Metrics






Article Access statistics

Viewed: 1865

PDF Downloaded: 615



Medical Abbreviation List